BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

BIOL 1.43 0.00 (0.00%)
price chart
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
Company Shares of Biolase, Inc. Drops by -10.98%
Biolase, Inc. (NASDAQ:BIOL) has lost 10.98% during the past week and dropped 21.08% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 8.96%.
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
Company Shares of Biolase, Inc. Rally 0.68%
Shares of Biolase, Inc. (NASDAQ:BIOL) appreciated by 0.68% during the past week but lost 13.02% on a 4-week basis. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 0.47%.
BIOLASE Receives Consensus Rating of "" from Analysts (NASDAQ:BLTI)  WKRB News
BIOLASE Announces Results of Annual Meeting
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office ...
BIOLASE Reports 2015 First Quarter Results  Business Wire (press release)
BIOLASE Comments on Recent Decline in Stock Price
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office ...
Biolase Jumps on CEO Comments  Orange County Business Journal
Biolase CEO Optimistic After Tumultuous Year
IRVINE, Calif., March 5, 2015 - The head of Biolase Inc. said he is confident the dental laser firm will grow in the new year after enduring a tumultuous 2014.
Biolase Report Could Presage Growth  Orange County Business Journal
BIOLASE Reports 2014 Fourth Quarter and Year-End Results  MarketWatch
BIOLASE Reports 2015 Second Quarter Results
New President and CEO Harold Flynn, Jr., who joined BIOLASE in mid-July, stated that “the Company demonstrated meaningful growth in its core laser franchises in the second quarter.
Biolase(NASDAQ:BIOL) Revenue Disclosure  OTC Outlook
BioLase Technology Inc.: BIOLASE Reports 2015 Second Quarter Results  The Wall Street Transcript
Shares of Biolase, Inc. (NASDAQ:BIOL) Rally 10.2%
Shares of Biolase, Inc. (NASDAQ:BIOL) appreciated by 10.2% during the past week but lost 4.71% on a 4-week basis. The shares have outperformed the S&P 500 by 11.6% in the past week but underperformed the index by 4.75% in the last 4 weeks.
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
Related articles »